ANXNF's logo.
Ticker Symbol: ANXNF

Annexin Pharmaceuticals AB

Exchange: US OTC Currency: USD Asset Type: Common Stock

Company Profile

Annexin Pharmaceuticals AB operates as a biotechnology company. It develops treatment of various cardiovascular diseases. The firm establishes and optimizes a cell line for large-scale production of Annexin A5. The company was founded by Anna Frostegård in 2014 and is headquartered in Stockholm, Sweden.

Sector: Health Technology
Industry: Pharmaceuticals: Major
Standard Industrial Classification Code (SIC code): 2834
Address: N/A
CEO: Jamal El-Mosleh
  • Health Technology
  • Pharmaceuticals: Major


Last Updated: December 31, 1969 07:00 PM EST
Previous Close: -
Change: - ( 0.00%)
Days Range: - - -
Beta: -
52wk. High: -
52wk. Low: -
Ytd. Change 0.00%
50 Day Moving Average: -
200 Day Moving Average: -
Shares Outstanding: 137240061


Market Cap: -
PE Ratio: -
EPS (TTM): 0


Dividend Per Share (TTM): -
Dividend Yield (TTM): 0.00%
Ex-Dividend Date: N/A